---
title: "Organon's Q4 Adjusted Earnings Rise, Revenue Declines; 2025 Sales Guidance Set"
date: "2025-02-13 21:39:50"
summary: "Organon reported Q4 adjusted earnings Thursday of $0.90 per diluted share, up from $0.88 a year earlier. Analysts polled by FactSet expected $0.87. Revenue for the quarter ended Dec. 31 was $1.59 billion, compared with $1.60 billion a year earlier. Analysts surveyed by FactSet expected $1.59 billion. For 2025, Organon..."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Organon reported Q4 adjusted earnings Thursday of $0.90 per diluted share, up from $0.88 a year earlier.

Analysts polled by FactSet expected $0.87.

Revenue for the quarter ended Dec. 31 was $1.59 billion, compared with $1.60 billion a year earlier.

Analysts surveyed by FactSet expected $1.59 billion.

For 2025, Organon said it expects revenue in the range of $6.13 billion to $6.33 billion.

Analysts polled by FactSet expect $6.43 billion.

Organon shares were up over 2% in recent Thursday premarket activity.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250213:A3316720:0/)
